Segment Reporting - Operating Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Segment Reporting Information [Line Items]
Net sales	$ 355,351	$ 323,508
Selling, general and administrative expenses	107,486	94,428
Income from operations	41,033	35,922
Total other expense - net	(3,075)	(1,574)
Income before income taxes	37,958	34,348
Cardiovascular
Segment Reporting Information [Line Items]
Net sales	338,713	313,374
Cost of sales standard	138,440	133,066
Cost of sales other	37,784	35,302
Selling, general and administrative expenses	100,974	91,300
Research and development expenses	21,954	20,916
Other operating expenses	1,023	(117)
Income from operations	38,538	32,907
Endoscopy
Segment Reporting Information [Line Items]
Net sales	16,638	10,134
Cost of sales standard	4,363	3,109
Cost of sales other	2,744	316
Selling, general and administrative expenses	6,512	3,128
Research and development expenses	524	566
Income from operations	$ 2,495	$ 3,015